Chengdu Ucello Biotechnology Co., Ltd.
Chengdu Ucello Biotechnology Co., Ltd.
Explore linked clinical trials.5 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Autologous Bedside CD19 CAR T-cell Therapy for B-ALL | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Not yet recruiting | Early phase 1 | 2025-12-11 | NCT07277504 | |
| Allogeneic UCB-derived CAR-T for SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Recruiting | Early phase 1 | 2025-12-10 | NCT07274059 | |
| CD19/BCMA CAR-T for SLE | Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosus | Not yet recruiting | Early phase 1 | 2025-12-05 | NCT07266337 | |
| CAR-T for Claudin18.2 Positive Solid Tumors | Claudin18.2 Positive Advanced Solid Tumors | Not yet recruiting | Early phase 1 | 2025-12-05 | NCT07266311 | |
| Allogeneic UCB-derived CAR-T for B-ALL | B-cell neoplasm, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Neoplasms by Histologic Type, Tumor Virus Infections, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, viral infectious disease | Not yet recruiting | Early phase 1 | 2025-12-01 | NCT07256353 |